StockData
Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV (LKFT) stock

LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Financials through fiscal 2025, year ended Dec 31, 2025Score 7/30
$34.39−0.40 (-1.15%)

Close on Nov 17, 2026Market cap $2.27BP/E 6.4Yield –

Lakefront Biotherapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Lakefront Biotherapeutics's price to sales ratio was 1.8× on Nov 11, 2026, against 6.5× a year earlier. Over the last 5 years it ranged from 1.4× to 15.6×, with a median of 7.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.8×−4.9
2025Dec 31, 20256.7×−0.6
2024Dec 31, 20247.3×−2.7
2023Dec 29, 202310.0×−1.6
2022Dec 30, 202211.6×+5.0
2021Dec 31, 20216.6×+1.0
2020Dec 31, 20205.6×−28.9
2019Dec 31, 201934.5×+3.3
2018Dec 31, 201831.2×+2.7
2017Dec 29, 201728.5×−26.4
2016Dec 30, 201654.9×–

More Lakefront Biotherapeutics figures

See a number that looks wrong?